Nicholas Johann, Evans Rebecca, Shaw Catriona, Dawnay Anne
Royal Wolverhampton NHS Trust, UK.
Nephron. 2016;132 Suppl 1:195-236. doi: 10.1159/000444823. Epub 2016 Apr 19.
In 2014 57.5% of HD patients and 62.7% of PD patients achieved the audit measure for phosphate. 29.0% of HD and 30.3% of PD patients had a serum phosphate above the audit standard range. 79.1% of HD and 79.7% of PD patients had adjusted calcium between 2.2–2.5 mmol/L. 57.4% of HD and 65.0% of PD patients had a serum PTH between 16–72 pmol/L. 16.4% of HD and 12.0% of PD patients had a serum PTH .72 pmol/L. Simultaneous control of all three parameters within current audit standards was achieved by 50.3% of HD and 52.5% of PD patients. 60.4% of HD and 81.8% of PD patients achieved the audit measure for bicarbonate.
2014年，57.5%的血液透析患者和62.7%的腹膜透析患者达到了磷酸盐的审核标准。29.0%的血液透析患者和30.3%的腹膜透析患者血清磷酸盐高于审核标准范围。79.1%的血液透析患者和79.7%的腹膜透析患者校正钙在2.2 - 2.5毫摩尔/升之间。57.4%的血液透析患者和65.0%的腹膜透析患者血清甲状旁腺激素在16 - 72皮摩尔/升之间。16.4%的血液透析患者和12.0%的腹膜透析患者血清甲状旁腺激素＞72皮摩尔/升。50.3%的血液透析患者和52.5%的腹膜透析患者在当前审核标准内实现了所有三个参数的同时控制。60.4%的血液透析患者和81.8%的腹膜透析患者达到了碳酸氢盐的审核标准。
Zotero 插件